BJA Advance Access originally published online on January 28, 2005
British Journal of Anaesthesia 2005 94(4):434-437; doi:10.1093/bja/aei081
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Precision and bias of target controlled propofol infusion for sedation
Departments of Anesthesiology, Statistics, Pediatrics, and Biomedical Engineering, University of Florida Colleges of Medicine and Engineering, Gainesville, Florida, USA
* Corresponding author. University of Alabama, Department of Anesthesiology, University of Alabama at Birmingham, Jefferson Tower, Room 920, 619 South 19th Street, Birmingham, AL 35249-0001, USA. E-mail: froelich{at}uab.edu
Background. The purpose of this study is to test precision and systematic bias of a target controlled infusion (TCI) of propofol in human volunteers at two sedative concentrations.
Methods. We studied the Diprifusor model (Marsh Pharmacokinetics and a Graseby® 3400 infusion pump) in 18 human volunteers at two sedative target plasma concentrations (0.5 and 1.0 µg ml1). Twenty minutes after infusion start or change and 20 min after discontinuation of the infusion plasma propofol concentrations were measured using liquid chromatographymass spectroscopy (LC-MS). Plasma propofol concentrations were compared with concentrations predicted by the TCI system. Agreement of those two measures (precision and bias) was determined using regression analysis.
Results. We found little systematic bias but poor precision. When setting the TCI system to deliver a plasma concentration of 1.0 µg ml1 one can predict the actual plasma concentration with 95% confidence only within a range of 0.441.38 µg ml1.
Conclusions. This finding helps to explain differences in responses to propofol sedation; pharmacokinetic variability appears to be an important factor.
Presented in abstract format at the World Congress of Anaesthesiology, Paris, 2004.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. B. Glen and F. Servin Evaluation of the predictive performance of four pharmacokinetic models for propofol Br. J. Anaesth., May 1, 2009; 102(5): 626 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Karalapillai, K. Leslie, A. Umranikar, and A. R. Bjorksten Nitrous oxide and anesthetic requirement for loss of response to command during propofol anesthesia. Anesth. Analg., April 1, 2006; 102(4): 1088 - 1093. [Abstract] [Full Text] [PDF] |
||||

